SCHEMBL9905780

SCHEMBL9905780

CC(C)(C)NC(=NC(=O)c1ccc(C(F)(F)F)cc1)Nc1cc(-c2cccc(OCc3ccccc3)c2)n[nH]1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL2L1 Q07817 1/20 0.43
MCL1 Q07820 1/20 0.43
MAOB P27338 2/20 0.42
IGF1R P08069 1/20 0.40
MET P08581 1/20 0.40
SRC P12931 1/20 0.40
PDK1 Q15118 1/20 0.40
PDK2 Q15119 1/20 0.40
PDK3 Q15120 1/20 0.40
PDK4 Q16654 1/20 0.40
SLC2A1 P11166 1/20 0.39
NR1H4 Q96RI1 1/20 0.39
MRGPRX4 Q96LA9 2/20 0.39
F10 P00742 1/20 0.39
NR4A2 P43354 1/20 0.38
PPARA Q07869 1/20 0.38
GPR132 Q9UNW8 1/20 0.38
NR1H2 P55055 2/20 0.38
PSEN1 P49768 1/20 0.38
PSEN2 P49810 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9905384 1.00 BCL2L1 (0.43) BCL2L1MCL1MAOBIGF1RMET
SCHEMBL9905383 1.00 BCL2L1 (0.43) BCL2L1MCL1MAOBIGF1RMET
SCHEMBL19360274 0.92 MRGPRX4 (0.42) BCL2L1MCL1MAOBPDK1PDK2
SCHEMBL9905736 0.92 MRGPRX4 (0.42) BCL2L1MCL1MAOBMRGPRX4NR4A2
SCHEMBL9905738 0.92 MRGPRX4 (0.42) BCL2L1MCL1MAOBMRGPRX4NR4A2
SCHEMBL9905739 0.92 MRGPRX4 (0.42) BCL2L1MCL1MAOBMRGPRX4NR4A2
SCHEMBL17088954 0.91 MAPT (0.41) MAOBPDK1PDK2PDK3PDK4
SCHEMBL18558030 0.87 GRM5 (0.41) MAPK14
SCHEMBL9905766 0.87 PPIA (0.40) MRGPRX4PPARD
SCHEMBL9905250 0.87 PPIA (0.40) MRGPRX4PPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2648511-A1 PYRAZOLYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF Lycera Corporation (US) 2013-10-16 EP disclosed
WO-2012078874-A1 PYRAZOLYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF LYCERA CORPORATION (US) 2012-06-14 WO disclosed